Google CEO Sundar Pichai says ‘AI shift’ opens opportunities to invest in startups
Alphabet is in investor in some of the highest-valued private companies, including SpaceX, Anthropic and Stripe.
Dow jumps 1,300 points for best day since April 2025 as U.S.-Iran ceasefire pushes oil lower: Live updates
Trump said the “double sided” ceasefire was contingent on Iran agreeing to an opening of the Strait of Hormuz.
Elon Musk seeks ouster of OpenAI CEO Sam Altman as part of lawsuit
Elon Musk is seeking to have OpenAI CEO Sam Altman and President Greg Brockman removed from their roles as officers in the company as part of a lawsuit.
Trump praises Hungary PM Viktor Orbán after Vance calls him at Budapest rally
Vance said he was not there to tell Hungarians how to vote, but later told them to “go to the polls” and “stand with Viktor Orbán, because he stands for you.”
Strait of Hormuz blockage upends global helium supply. This U.S. company could benefit
UBS thinks Exxon Mobil shares have at least another 5% left in them.
Apple shares sink on report of foldable iPhone delays
The company is reportedly facing engineering challenges in the development of the foldable phones, which are anticipated to launch later this year.
Broadcom lands big deal for its specialty chips. Wall Street sees the stock rising as much as 80%
Broadcom is likely to gain a lot of ground on its recent deals with Google and Anthropic, according to several shops on the Street.
Danone CEO flags price uncertainty as Iran war escalates: ‘Nobody knows’ how conflict will play out
Consumer goods companies increasingly take stock of how the Iran war may impact their operations and costs base, as the conflict enters its sixth week.
Danone CEO flags price uncertainty as Iran war escalates: ‘Nobody knows’ how conflict will play out
Consumer goods companies increasingly take stock of how the Iran war may impact their operations and costs base, as the conflict enters its sixth week.
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
